2 Trulicity was first approved in September 2014 as a once-weekly injectable prescription medicine to improve blood sugar (glucose) in adults with type 2 diabetes, based in part on results from five Phase 3 studies of Trulicity used alone or in combination with other diabetes medications, including metformin, pioglitazone, glimepiride and insulin lispro
Furthermore, flow cytometry analysis demonstrated that knockdown of SLC25A39 increased the rate of cell apoptosis compared to controls, whereas overexpression of SLC25A39 exhibited the opposite effect (Fig
The catch is that lower dose is not automatically same result at less risk. A dose that is too low for your biology may simply underperform while still carrying side effects
This makes it dry and easier for irritants to enter
Regional defects, such as blunted antral contractions, spastic pyloric and small intestinal motility, hypersensitivity to fundic distention and impaired gastric accommodation to meals are demonstrable in diabetic patients
Too much homocysteine can lead to blood clots or blood vessel blockages